Stockscreener 앱 받기
37.00
2.50%
-0.95
시장 영업 전:
36.65
-0.35
-0.95%
Newamsterdam Pharma Company Nv (NAMS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
542.88%
19.14
|
2.978 | 12.77 | 29.11 | 1.401 |
Operating Expenses
|
23.81%
54.78
|
71.90 | 56.00 | 54.11 | 56.88 |
| Benefits Costs and Expenses |
14.11%
36.51
|
42.51 | 104.95 | 45.76 | 95.17 |
| Costs And Expenses |
14.11%
36.51
|
42.51 | 104.95 | 45.76 | 95.17 |
| Depreciation and Amortization |
5.31%
0.107
|
0.113 | - | - | - |
| Operating Income/Loss |
48.30%
-35.63
|
-68.92 | -43.23 | -25.00 | -55.48 |
| Income/Loss From Continuing Operations Before Tax |
56.07%
-17.36
|
-39.53 | -92.18 | -16.65 | -93.77 |
| Income/Loss From Continuing Operations After Tax |
56.07%
-17.36
|
-39.53 | -92.18 | -16.65 | -93.77 |
|
Net Income/Loss
|
56.07%
-17.36
|
-39.53 | -92.18 | -16.65 | -93.77 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2.09%
118.56
|
116.12 | 1.6912 | 94.75 | 88.38 |
| Diluted Average Shares |
2.09%
118.56
|
116.12 | 1.6912 | 94.75 | 88.38 |
| Basic Earnings Per Share |
55.88%
-0.15
|
-0.34 | -0.95 | -0.18 | -1.06 |
| Diluted Earnings Per Share |
55.88%
-0.15
|
-0.34 | -0.95 | -0.18 | -1.06 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
자본화:
|
볼륨(24시간):